Scientific article

Maladies infectieuses : ce qui a changé en 2023

Published inRevue médicale suisse, vol. 20, no. 856-857, p. 55-58
Publication date2024-01-17

The year 2023 saw the publication of several studies in various areas of infectious diseases. The administration of corticosteroids decreased mortality in severe community-acquired pneumonia. Administration of doxycycline post-exposure prophylaxis reduced the risk of bacterial sexually transmitted infections at the risk of resistance selection. An herbal preparation decreased mortality in sepsis. A meta-analysis concludes that oseltamivir does not significantly reduce the risk of hospitalisation for influenza. Discontinuation of antibiotic prophylaxis during dental procedures in Sweden did not increase the incidence of viridans group Streptococcus endocarditis. Several studies have led to the introduction of RSV (Respiratory Syncytial Virus (RSV) vaccination. 2023 also saw the resurgence of invasive Group A Streptococcal infections, of which clinicians must be wary.

  • Humans
  • Communicable Diseases
  • Sepsis
  • Streptococcal Infections
  • Influenza, Human
  • Doxycycline
Citation (ISO format)
D’INCAU, Stéphanie et al. Maladies infectieuses : ce qui a changé en 2023. In: Revue médicale suisse, 2024, vol. 20, n° 856-857, p. 55–58. doi: 10.53738/REVMED.2024.20.856-7.55
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 07/18/2025
ISSN of the journal1660-9379

Technical informations

Creation02/29/2024 10:32:20 AM
First validation03/13/2024 9:08:04 AM
Update time03/13/2024 9:08:04 AM
Status update03/13/2024 9:08:04 AM
Last indexation03/13/2024 9:08:24 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack